Unhealthy drinking Not Applicable
Conditions
Interventions
Pilot Trial
The pilot trial will compare two groups of patients: those who will have the MAC, and those who will have medicines reviews as they are now. A computer will decide into whi
three interviews with two pharmacists as they progress through the training
post-training audio recording of at least one consultation from each pharmacist to explore skills development
telephone interviews conducted within one
Sponsors
University of York
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1. Aged 18 years or older 2. Screen positive for unhealthy drinking on a single item alcohol screening question (AUDIT question 1, for frequency of drinking) 3. Using pharmacy medication review services Any participant in the CHAMP-1 pilot trial who provides a mobile number and agrees on the consent form to receive text messages will be eligible for the text message SWAT. Pharmacies: 1. Conducting Medicines Use Reviews during the study period 2. Agree to audio record consultations (with patient consent) 3. Agree to participate in training as required, including GCP and informed consent training delivered by Yorkshire and Humber CRN
Exclusion criteria
Exclusion criteria: 1. Patients in receipt of alcohol treatment in the previous 12 months 2. Participants who do not provide a mobile number or consent to receive texts will be excluded from the text message SWAT
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Total weekly alcohol consumption, measured using a retrospective diary in the 7 days prior to follow-up at 2 months 2. Medications management, measured using PROMIS Self-Efficacy for Managing Medications and Treatment - 8a at 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Heavy drinking and drinking within recommended weekly guidelines, derived from primary alcohol measure at 2 months 2. Adherence measured by ProMAS at 2 months 3. Anxiety (GAD-7) and depression (PHQ-8) measured at 2 months 4. Quality of life measured by the EQ-5D-5L at 2 months | — |
Countries
England, United Kingdom
Outcome results
None listed